ALGINOR ASA

Their core work

Alginor is a Norwegian SME specializing in total utilization of ocean biomass, particularly seaweed and macroalgae. They developed and commercialized the AORTA technology — a biorefinery process that extracts maximum value from marine raw materials. Their work spans from kelp harvesting and processing to producing high-value ingredients for food, feed, and industrial applications. They have taken their core technology from feasibility study through to full-scale demonstration and commercialization within H2020.

What they specialise in

How they've shifted over time

Alginor's H2020 trajectory shows a textbook technology maturation path. Their early projects (2017–2020) focused on developing and refining their proprietary AORTA ocean biorefinery process, progressing from a feasibility study (SME-1) to a full innovation project (SME-2). By 2020, they shifted toward commercialization (DACOTA) and broadened into sustainable protein applications (ALEHOOP), signaling a move from pure technology development into food-system applications of their marine processing capabilities.

Alginor is transitioning from a technology developer to a market-ready supplier of marine-derived ingredients for food and feed, making them increasingly relevant for sustainable protein and circular bioeconomy consortia.

How they like to work

Alginor strongly prefers to lead — they coordinated 3 of their 4 projects, driving their own technology agenda through the SME Instrument and Innovation Action tracks. Their single participation as partner (ALEHOOP) shows they can also contribute specialist knowledge to larger consortia when the topic aligns. With 17 partners across 6 countries, they maintain a moderate but purposeful network, selecting collaborators who complement their marine biorefinery core.

Alginor has worked with 17 unique partners across 6 countries, building a focused European network centered on marine bioprocessing and food innovation. Their geographic reach reflects targeted partnerships rather than broad networking.

What sets them apart

Alginor occupies a rare niche as an SME that owns a proprietary seaweed biorefinery process and has taken it from concept to commercial demonstration entirely within H2020 funding. Unlike academic groups studying algae or large companies with broad portfolios, they offer deep, focused expertise in marine total-utilization processing with a clear path to industrial-scale production. For consortium builders, they bring both the technology and the commercialization drive that funders want to see.

Highlights from their portfolio

• DACOTA
  Largest single grant (EUR 2.5M) — a demonstration and commercialization project, indicating their AORTA technology reached market-readiness within H2020.
• ALEHOOP
  Their only project as partner, connecting macroalgae biorefinery expertise to the growing sustainable protein and alternative feed sector through a multi-partner Innovation Action.